AzTrials
AzTrials

Intellectual DisabilityNCT03033797

Augmentative and Alternative Communication in Games With Virtual Reality in Intellectual Disabilities

A study testing MoviLetrando and MoveHero in people with Intellectual Disability, run by Faculdade de Medicina do ABC at 1 site in Brazil.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Background: Games using motion capture from webcam have become increasingly popular. A population that lacks much stimulus in the teaching-learning process has under-explored the benefits of this kind of games: The Intellectually Disabled. Read more about this study

Who is it for?
Ages 7 to 14 years
Conditions the study is for
Intellectual Disability
What is being tested?
MoviLetrando and MoveHero
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
165 participants
Where
1 siteBrazil
Study dates
8 Mar 2016to 24 Mar 2018
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 7 to 14 years
  • All sexes
  • No healthy volunteers
  • Child

Who may be able to join

  • All the children that uses to go the institution where the data collection will be realised (APAE).

Who cannot join

  • Those who decline to participate
  • Those who are not present in the two days of evaluation.

Trial locations and contacts

1 site in 1 country.

Regiani Guarnieri contact

4899344597

regianig1@gmail.com

Brazil1 site, 1 recruiting
  • Associação de Pais e Amigos dos Excepcionais

    São Paulo, 04040-033

    Viviane AM Perico, +551150807009 ext. 345, vivianeperico@apaesp.org.br

    Recruiting

Other trials in Brazil

About this study

Background: Games using motion capture from webcam have become increasingly popular. A population that lacks much stimulus in the teaching-learning process has under-explored the benefits of this kind of games: The Intellectually Disabled. The aim of this study is to analyse the effectiveness of games with virtual reality in the total reaction time. Method: A convenience sample of 165 Intellectually Disabled participants will have their performance measured using a virtual reality game. The intervention is to play two different games twice, in two sessions with an interval of, at least, seven days between the sessions. Participants will be randomized between two raters, both master students.

Being tested
MoviLetrando, MoveHero
Keywords
assitive technology, virtual reality games, intellectual disability, augmentative and alternative communication
Medical subject headings
Intellectual Disability

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • MoviLetrandoDevice

    Half of the participants will play two different levels of the Game MoviLetrando, two minutes each.

  • MoveHeroDevice

    Half of the participants will play 2 minutes of the game MoveHero.

Study groups in NCT03033797
Study groupRoleWhat they receive
MoviLetrando-MoveHeroExperimentalHalf of the children will play first two different levels of the game MoviLetrando (2 minutes each) and, after the game MoveHero, more 2 minutes
Receives: Device: MoviLetrando; Device: MoveHero
MoveHero-MoviLetrandoExperimentalThe other half of the children will play first 2 minutes of the game MoveHero and after, two different levels of the Game MoviLetrando, two minutes each.
Receives: Device: MoviLetrando; Device: MoveHero

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. total reaction time

    decrease in time indicates a better performance

    Measured: 6 minutes

Secondary outcomes (2)
  1. time MoviLetrando

    less time to hit the targets indicates a better performance

    Measured: up to 15 days

  2. acerts MoviLetrando

    more hits indicates a better performance

    Measured: up to 15 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Jan 2017 (estimated)
  2. Study start8 Mar 2016
  3. Primary completion10 Mar 2018 (estimated)
  4. Study completion24 Mar 2018 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Prevention
Allocation
Randomised
Intervention model
Crossover
Masking
None (open label)
Enrolment
165 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03033797
Sponsor's protocol ID
54172416.6.0000.0082
Status last verified
Aug 2017
First submitted
20 Jan 2017
Last updated
16 Aug 2017
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing MoviLetrando and MoveHero in people with Intellectual Disability, run by Faculdade de Medicina do ABC at 1 site in Brazil.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 16 Aug 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Brazil. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Regiani Guarnieri (4899344597, regianig1@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

total reaction time (time frame: 6 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Aug 2017; AzTrials last refreshed its copy on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in